Delivery Order SPE2DB20D1004-SPE2DB22FF3V2
Award Date 3/16/22
Potential Completion Date 3/17/22
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Budesonide-Formoterol 80-4.5 10.2GM, a pharmaceutical product. The Firm Fixed Price delivery order contract, valued at $1,047.99, has a period of performance through September 4, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,205.56 firm fixed-price delivery order is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medication used to treat respiratory conditions. The contract has an ultimate completion date of April 11, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00...
- This federal contract award, valued at $1,884.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 22, 2023. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Budesonide-Formoterol 160-4.5 10.2GM medical products. The fixed-price contract has a ceiling value of $8,422.79 and an ultimate completion date of January 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The $1,515.72 firm fixed-price delivery order is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a medication used to treat asthma and chronic obstructive pulmonary disease. The contract has an ultimate completion date of September 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Budesonide-Formoterol 160-4.5 10.2GM medication. The $1,833.46 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 1, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,106.76 firm-fixed-price delivery order is for the supply of Budesonide-Formoterol 160-4.5 10.2GM, a respiratory medication. The contract has an ultimate completion date of October 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,142.84 firm fixed-price delivery order is for the supply of Budesonide-Formoterol 80-4.5 10.2GM, a respiratory medication, with a completion date of June 5, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the delivery of Budesonide-Formoterol 160-4.5 10.2GM medication. The $1,170.73 firm fixed price delivery order has a completion date of March 11, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order with a firm fixed price valued at $2,921.57. The award is for the procurement of Budesonide-Formoterol 160-4.5 10.2GM, a pharmaceutical product, with a completion date of February 6, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...